References
- Trapnell BC, Nakata K, Bonella F, et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers. 2019;5(1):16. doi:10.1038/s41572-019-0066-3.
- Inoue Y, Trapnell BC, Tazawa R, Japanese Center of the Rare Lung Diseases Consortium, et al. Characteristics of a Large Cohort of Patients with Autoimmune Pulmonary Alveolar Proteinosis in Japan. Am J Respir Crit Care Med. 2008;177(7):752–762. doi:10.1164/rccm.200708-1271OC.
- McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC. Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2018;13(1):129. doi:10.1186/s13023-018-0846-y.
- Trapnell BC, Whitsett JA, Nakata K. Pulmonary Alveolar Proteinosis. N Engl J Med. 2003;349(26):2527–2539. doi:10.1056/NEJMra023226.
- Rossi SE, Erasmus JJ, Volpacchio M, Franquet T, Castiglioni T, McAdams HP. "Crazy-paving" pattern at thin-section CT of the lungs: radiologic-pathologic overview”. Radiographics. 2003;23(6):1509–1519. doi:10.1148/rg.236035101.
- De Wever W, Meersschaert J, Coolen J, Verbeken E, Verschakelen JA. The crazy-paving pattern: a radiological-pathological correlation. Insights Imaging. 2011;2(2):117–132. doi:10.1007/s13244-010-0060-5.
- Jouneau S, Ménard C, Lederlin M. Pulmonary alveolar proteinosis. Respirology. 2020;25(8):816–826. doi:10.1111/resp.13831.
- Seymour JF, Presneill JJ. Pulmonary Alveolar Proteinosis: Progress in the First 44 Years. Am J Respir Crit Care Med. 2002;166(2):215–235. doi:10.1164/rccm.2109105.
- Zhao YY, Huang H, Liu YZ, Song XY, Li S, Xu ZJ. Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Long-term Follow-up Study. Chin Med J (Engl). 2015;128(20):2714–2719. doi:10.4103/0366-6999.167295.
- Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. N Engl J Med. 2019;381(10):923–932. doi:10.1056/NEJMoa1816216.